Angiopoietin like 4 as a clinical biomarker for acute respiratory distress syndrome Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019
Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for severe acute respiratory syndrome coronavirus 2 patients Source: Eur Respir J, 56 (5) 2001531; 10.1183/13993003.01531-2020 Year: 2020
Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome Source: Eur Respir Rev, 29 (156) 200114; 10.1183/16000617.0114-2020 Year: 2020
Pathogenesis of acute microvascular lung injury and the acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=22 Year: 2002
Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management Year: 2006
Early intervention with non-invasive respiratory therapies in mild acute respiratory distress syndrome secondary to COVID-19 Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021
Phenotypes of acute respiratory distress syndrome Source: Virtual Congress 2021 – Respiratory critical care Year: 2021
The therapeutic potential of a new phosphodiesterase inhibitor in acute respiratory distress syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 36s Year: 2002
Characterization of small airways structural alterations in acute respiratory distress syndrome Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008
The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance Source: Eur Respir J 2014; 43: 276-285 Year: 2004
Epidemiology and prognosis of acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=1 Year: 2002
An animal model of the acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 486s Year: 2002
Corticosteroids in acute respiratory distress syndrome Source: Virtual Congress 2021 – Respiratory critical care Year: 2021
Overview of current lung imaging in acute respiratory distress syndrome Source: Eur Respir Rev 2014; 23: 519-530 Year: 2014
Predictive factors for non-invasive ventilation failure during acute respiratory distress syndrome Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020
COVID-19 patient with acute respiratory distress syndrome (ARDS) benefit most from an early prone position Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021
Diversity of the lung mycobiome is associated with severity of disease in acute respiratory distress syndrome Source: Virtual Congress 2020 – New insights into mechanical ventilation in the intensive care unit Year: 2020
Exogenous surfactant in acute respiratory distress syndrome: more is better Source: Eur Respir J 2002; 19: 787-789 Year: 2002
The predictive role of inflammatory markers and CD 95 for acute respiratory distress syndrome development and outcome Source: Eur Respir J 2006; 28: Suppl. 50, 347s Year: 2006